ORGANOGENESIS INC
3, 1998-09-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: JONES CABLE INCOME FUND 1-A LTD, 8-K, 1998-09-28
Next: RESPIRONICS INC, 10-K, 1998-09-28



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person
   Stanmore Associates, L.P.
   41 East 42nd Street
   New York, New York  10017
2. Date of Event Requiring Statement (Month/Day/Year)
   9/18/98
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Issuer Name and Ticker or Trading Symbol
   Organogenesis, Inc. (ORG)
   
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director  (X) 10% Owner  ( ) Officer (give title below) ( ) Other
   (specify below)
   
6. If Amendment, Date of Original (Month/Day/Year)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   (X) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Beneficially Owned                                                                           |
___________________________________________________________________________________________________________________________________|
1. Title of Security                       |2. Amount of          |3. Ownership    |4. Nature of Indirect                          |
                                           |   Securities         |   Form:        |   Beneficial Ownership                        |
                                           |   Beneficially       |   Direct(D) or |                                               |
                                           |   Owned              |   Indirect(I)  |                                               |
___________________________________________________________________________________________________________________________________|
<S>                                        <C>                    <C>              <C>
Common Stock                               | 2,984,214 (1)        |   (1)          |     (1)                                       |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>

                                  1 of 4 Pages

<PAGE>

___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Beneficially Owned                                                                             |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative   |2.Date Exer-       |3.Title and Amount     |         |4. Conver-|5. Owner-    |6. Nature of Indirect      |
  Security              |  cisable and      |  of Underlying        |         |sion or   |ship         |   Beneficial Ownership    |
                        |  Expiration       |  Securities           |         |exercise  |Form of      |                           |
                        |  Date(Month/      |-----------------------|---------|price of  |Deriv-       |                           |
                        |  Day/Year)        |                       |Amount   |deri-     |ative        |                           |
                        | Date    | Expira- |                       |or       |vative    |Security:    |                           |
                        | Exer-   | tion    |         Title         |Number of|Security  |Direct(D) or |                           |
                        | cisable | Date    |                       |Shares   |          |Indirect(I)  |                           |
___________________________________________________________________________________________________________________________________|
<S>                     <C>       <C>       <C>                     <C>       <C>        <C>           <C>
                        |         |         |                       |         |          |             |                           |
                        |         |         |                       |         |          |             |                           |
                        |         |         |                       |         |          |             |                           |
                        |         |         |                       |         |          |             |                           |
                        |         |         |                       |         |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) See Schedule I.

Stanmore Associates, L.P.                     
By: Stanmore Corporation, its General Partner 
                                              
     /s/Albert Erani                 9/28/98
    ----------------------------------------
By: Albert Erani, President                   
(** signature of Reporting Person)            
                                              

                                  2 of 4 Pages



<PAGE>




                                   SCHEDULE I


         This   Statement   is  being   filed  by  Stanmore   Associates,   L.P.
("Stanmore");  by Stanmore  Corporation;  by Alan Ades and his wife, Ita Josette
Ades, and their sons,  Maurice and Robert; by Albert Erani and his wife, Barbara
Erani; and by Dennis Erani, the brother of Albert (collectively,  the "Reporting
Persons").  Reference  is made to the  Statement on Schedule  13D,  filed by the
Reporting  Persons with the  Securities  and Exchange  Commission on January 24,
1997, as amended on September 30, 1997 and April 8, 1998.

         The Reporting Persons beneficially own an aggregate of 2,984,214 shares
of Common Stock, representing approximately 10.2% of the shares of Common Stock.
Stanmore   beneficially  owns  3,000  of  such  shares;   Stanmore   Corporation
beneficially owns 3,000 of such shares; Alan Ades beneficially owns 1,332,156 of
such shares;  Ita Josette Ades beneficially  owns 5,250 of such shares;  Maurice
Ades  beneficially  owns 50,000 of such shares;  Robert Ades  beneficially  owns
38,500 of such shares;  Dennis Erani  beneficially  owns 232,500 of such shares;
Albert Erani  beneficially  owns  1,448,183 of such  shares;  and Barbara  Erani
beneficially owns 83,543 of such shares.

         By reason of its  position  as general  partner of  Stanmore,  Stanmore
Corporation may be deemed to possess the power to vote and dispose of the shares
of  Common  Stock  beneficially  owned  by  Stanmore.  Pursuant  to  Rule  13d-4
promulgated under the Securities Act of 1934, as amended,  Stanmore  Corporation
disclaims  beneficial  ownership of such shares. By reason of their positions as
officers and directors of Stanmore  Corporation,  Alan Ades and Albert Erani may
be deemed to possess the power to vote and dispose of the shares of Common Stock
beneficially  owned by Stanmore.  Pursuant to Rule 13d-4  promulgated  under the
Securities Exchange Act of 1934, as amended, Alan Ades and Albert Erani disclaim
beneficial ownership of such shares.

         The shares  held by Albert and  Barbara  Erani  include  shares held as
custodians  under the New York  Uniform  Gift to Minors  Act for the  benefit of
their  children,  Robert,  David  and Emily  Erani,  and thus they may be deemed
beneficial owners of such shares.

         The shares held by Alan Ades include  shares held as  custodians  under
the New York Uniform Gift to Minors Act for the benefit of his daughter, Rebecca
Ades, and thus he may be deemed beneficial owner of such shares.

         The shares held by Dennis Erani include shares held as custodian  under
the New York Uniform Gift to Minors Act for the benefit of his children,  Robert
H.  and  Emily G.  Erani,  and thus he may be  deemed  beneficial  owner of such
shares.

         The  shares  jointly  held by Alan Ades and Albert  Erani also  include
shares  held by  various  corporate  pension  plans,  of which they are the sole
trustees, and thus they may be deemed beneficial owners of such shares. Pursuant
to Rule 13d-4 of the Securities Exchange Act of 1934, as amended,  Alan Ades and
Albert Erani expressly disclaim beneficial ownership of such shares.


                                Page 3 of 4 pages



<PAGE>


                             Joint Filer Information
                             -----------------------



Names:         Stanmore Corporation
               Alan Ades
               Ita Josette Ades
               Maurice Ades
               Robert Ades
               Albert Erani
               Barbara Erani
               Dennis Erani

Address:       c/o Stanmore Associates, L.P.
               41 East 42nd Street
               New York, New York  10017

Designated Filer: Stanmore Associates, L.P.

Issuer and
Ticker Symbol:    Organogenesis, Inc. (ORG)

Date of Event
Requiring Statement:         September 18, 1998

Signatures:

Stanmore Corporation

By: /s/ Albert Erani
   -----------------
    Albert Erani
    President

/s/ Alan Ades
- -------------

/s/ Ita Josette Ades
- --------------------

/s/ Maurice Ades
- ----------------

/s/ Robert Ades
- ---------------

/s/ Albert Erani
- ----------------

/s/ Barbara Erani
- -----------------

/s/ Dennis Erani
- ----------------


                                Page 4 of 4 pages





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission